Featured today by @MSKLibrary: pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy

#MelanomaResearch #pTERTMutation #Immunotherapy #CancerGenomics #OncologyStudies #StageIVMelanoma #SurvivalBiomarkers

dx.doi.org/10.1016/j.ej...